BC Extra | Nov 11, 2019
Clinical News

DxTerity type I interferon biomarker study, launch bolsters lupus patient stratification

Data supporting the commercial launch of DxTerity’s type I interferon gene expression test in systemic lupus erythematosus (SLE) could lower barriers to signal detection in clinical trials by identifying patients who stand to benefit most...
BC Innovations | Jun 23, 2016
Distillery Therapeutics

Therapeutics: Interferon-stimulated gene 15 (ISG15); interferon induced protein with tetratricopeptide repeats 1 (IFIT1)

Infectious disease INDICATION: Viral infection Patient sample studies suggest inhibiting ISG15 could help treat viral infections. In vitro, stimulation with interferon α (IFNα) and IFNβ of fibroblasts from ISG15-deficient volunteers induced more persistent expression of...
BC Innovations | Apr 30, 2009
Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease Viral infection Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1; ISG56) Studies in cell culture suggest that inhibiting ISG56 could...
Items per page:
1 - 3 of 3